NCT02097303
Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2014
Completion: Dec 31, 2015